Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
FDA Oncology
Aug 25, 2024, 16:32 |
Blog
Francisco J. Esteva: Capivasertib combined with fulvestrant offers new hope in breast cancer
Francisco J. Esteva, Chief, Division of Hematology and Medical Oncology at Lenox Hill Hospital shared a…
Aug 25, 2024, 13:02 |
Insight
Toni Choueiri: Results from LITESPARK-005 are out
Toni Choueiri shared a post on X about a recent paper titled "Belzutifan versus Everolimus…
Aug 24, 2024, 11:47 |
Insight
Narjust Florez: Discussion with Julia Rotow about the MARIPOSA trial
Narjust Florez shared a post by IASLC on X, adding: “At The International Association for…
Aug 23, 2024, 14:21 |
Drugs
Stephen V Liu: How do we select the optimal regimen for EGFR NSCLC?
Stephen V Liu shared on X: "With FLAURA (osimertinib alone), FLAURA2 (osimertinib with chemotherapy), and…
Aug 22, 2024, 14:52 |
Blog
New Lung Cancer Considered Episode with Narjust Florez and Julia Rotow
Florez Lab shared a post on X: "FDA approved lazertinib + amivantamab for first-line treatment…
Aug 21, 2024, 16:40 |
Insight
Jeff Allen: How Can Real-World Data Be Used To Measure Treatment Response Rates?
Jeff Allen, President and CEO of Friends of Cancer Research, shared a post on LinkedIn:…
Aug 21, 2024, 14:43 |
Blog
Science Saturday of anti-LAG-3 and anti-PD1 for advance melanoma with Patrick Hwu
Patrick Hwu shared a post on X: "The combination of anti-LAG-3 and anti-PD1 antibodies is US…
Aug 20, 2024, 12:39 |
Insight
Patrick Hwu: How is the combination of anti-LAG-3 and anti-PD1 working mechanistically?
Patrick Hwu shared on X: “Science Sunday! The combination of anti-LAG-3 and anti-PD1 antibodies is…
Aug 20, 2024, 05:20 |
Dialogues
Low-Grade Lymphomas: Dr. Joshua Brody on Treatments, Strategies, and Innovations
In this episode of OncoDaily interviews, Dr. Joshua Brody, director of the lymphoma immunotherapy program…
Aug 19, 2024, 08:12 |
Insight
Vivek Subbiah: How does PARP Inhibitor affect BARD1-Mutated Neuroblastoma?
Vivek Subbiah shared on LinkedIn: "BARD1 = encodes the BRCA1-associated RING domain 1 protein which forms…
23
24
25
26
27
All:
562
Posts:
241 - 250
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024
Uniting Forces: Leveraging Cancer Research to Revolutionize Tuberculosis Treatment
World - first lung cancer vaccine trials launched across 7 countries
Lance Armstrong and Testicular Cancer: Story, Symptoms, Treatment
Honoring Jeff Weber, a giant in the field of oncology
Facebook
RSS Feed
Twitter
Linkedin
Youtube